Results 181 to 190 of about 379,741 (354)

Testing the efficacy of yoga as a complementary therapy for smoking cessation: Design and methods of the BreathEasy trial

, 2014
Beth C. Bock, Rochelle K. Rosen, Joseph L. Fava, Ronnesia B. Gaskins, Ernestine Jennings, Herpreet Thind, James Carmody, Shira Dunsiger, Naama Gidron, Bruce M. Becker, Bess H. Marcus   +10 more
openalex   +2 more sources

Alternative and complementary medicine: A source of improved therapies for asthma? A challenge for redefining the specialty? [PDF]

, 2000
Renata J.M. Engler
openalex   +1 more source

The PI3Kδ inhibitor roginolisib (IOA‐244) preserves T‐cell function and activity

Molecular Oncology, EarlyView.
Identification of novel PI3K inhibitors with limited immune‐related adverse effects is highly sought after. We found that roginolisib and idelalisib inhibit chronic lymphocytic leukemia (CLL) cells and Treg suppressive functions to similar extents, but roginolisib affects cytotoxic T‐cell function and promotion of pro‐inflammatory T helper subsets to a
Elise Solli, Alessio Bevilacqua, Mathias Wenes, Denis Migliorini, Lars van der Veen, Sigrid S Skånland, Giusy Di Conza, Kjetil Taskén   +7 more
wiley   +1 more source

Complementary Therapies for Diabetic Foot Ulcer Healing Among Patients in Asia: Scoping Review. [PDF]

Asian Pac Isl Nurs J
Yusran P ADM, Yusuf S, Burhan H, Taming MJ.   +3 more
europepmc   +1 more source

Alternative and Complementary Therapies against Foodborne Salmonella Infections. [PDF]

Antibiotics (Basel), 2021
Ghaly MF, Nasr ZM, Abousaty AI, Seadawy HG, Shaheen MAA, Albogami S, Al-Sanea MM, Bendary MM.   +7 more
europepmc   +1 more source

A complementary therapy approach to the management of individual stress among student nurses [PDF]

, 1993
Edward Lindop
openalex   +1 more source

Identification of serum protein biomarkers for pre‐cancerous lesions associated with pancreatic ductal adenocarcinoma

Molecular Oncology, EarlyView.
This work identified serum proteins associated with pancreatic epithelial neoplasms (PanINs) and early‐stage PDAC. Proteomics screens assessed genetically engineered mice with abundant PanINs, KPC mice (Lox‐STOP‐Lox‐KrasG12D/+ Lox‐STOP‐Lox‐Trp53R172H/+ Pdx1‐Cre) before PDAC development and also early‐stage PDAC patients (n = 31), compared to benign ...
Hannah Mearns, Jaclyn S. Long, Sergio Lilla, Kelly Hodge, Marcus J. G. W. Ladds, Colin Nixon, Paula Fernández‐Palanca, Sara Zanivan, Pilar Acedo, Stephen P. Pereira, Kevin M. Ryan   +10 more
wiley   +1 more source

Use of complementary therapies is associated with expectations of treatment effectiveness among persons with multiple sclerosis. [PDF]

BMJ Neurol Open
Stanikić M, Steinemann N, López-Alcalde J, Canella C, Barth J, Chan A, Roth P, Calabrese P, Zecca C, Gobbi C, Manjaly ZM, Ammann S, Kägi S, Baum C, Kamm CP, Puhan MA, Witt CM, von Wyl V, Swiss Multiple Sclerosis Registry.   +18 more
europepmc   +1 more source

Implementation and outcomes of complementary therapies in hospice care: an integrative review. [PDF]

Palliat Care Soc Pract, 2021
Dingley C, Ruckdeschel A, Kotula K, Lekhak N.   +3 more
europepmc   +1 more source

Subtype‐specific enhancer RNAs define transcriptional regulators and prognosis in breast cancers

Molecular Oncology, EarlyView.
This study employed machine learning methodologies to perform the subtype‐specific classification of RNA‐seq data sets, which are mapped on enhancers from TCGA‐derived breast cancer patients. Their integration with gene expression (referred to as ProxCReAM eRNAs) and chromatin accessibility profiles has the potential to identify lineage‐specific and ...
Aamena Y. Patel, Peyman Zarrineh, Nathnael T. Tuffa, Jigar H. Sheth, Sumitra Mohan, Mudassar Iqbal, Sankari Nagarajan   +6 more
wiley   +1 more source